Page last updated: 2024-08-22

stavudine and HIV Wasting Syndrome

stavudine has been researched along with HIV Wasting Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brophy, JC; Chan, AK; Hawkes, MT; Mateyu, G; Mwinjiwa, E; Sodhi, SK	1
Kumwenda, JJ; Manary, M; Moore, E; Ndekha, M; van Oosterhout, JJ; Zijlstra, EE	1
Andersen, O; Gerstoft, J; Katzenstein, TL; Kirk, O; Nielsen, H; Pedersen, C; Vinten, J; Worm, D	1
Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS	1
Bruno, F; Gastaut, JA; Lang, JM; Partisani, M; Poizot-Martin, I; Rouviere, O; Saint-Marc, T; Touraine, JL	1
Dankner, WM; Muelenaer, PA; Spector, SA; Viani, RM	1
James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB	1

Reviews

1 review(s) available for stavudine and HIV Wasting Syndrome

Article	Year
Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatrics, 1999, Volume: 104, Issue:6 Topics: AIDS-Associated Nephropathy; Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; Gastrostomy; HIV Protease Inhibitors; HIV Wasting Syndrome; HIV-1; Humans; Lamivudine; Nelfinavir; Nephrotic Syndrome; Remission Induction; Stavudine	1999

Article

Year

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

Pediatrics, 1999, Volume: 104, Issue:6

Topics: AIDS-Associated Nephropathy; Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; Gastrostomy; HIV Protease Inhibitors; HIV Wasting Syndrome; HIV-1; Humans; Lamivudine; Nelfinavir; Nephrotic Syndrome; Remission Induction; Stavudine

1999

Trials

1 trial(s) available for stavudine and HIV Wasting Syndrome

Article	Year
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance. HIV medicine, 2002, Volume: 3, Issue:4 Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Cross-Sectional Studies; Drug Therapy, Combination; Glucose Intolerance; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Hyperlipidemias; Indinavir; Lipodystrophy; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine; Surveys and Questionnaires	2002

Article

Year

Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.

HIV medicine, 2002, Volume: 3, Issue:4

Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Cross-Sectional Studies; Drug Therapy, Combination; Glucose Intolerance; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Hyperlipidemias; Indinavir; Lipodystrophy; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine; Surveys and Questionnaires

2002

Other Studies

6 other study(ies) available for stavudine and HIV Wasting Syndrome

Article	Year
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi. PloS one, 2016, Volume: 11, Issue:11 Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleotides; Female; HIV Infections; HIV Wasting Syndrome; Humans; Infant; Lamivudine; Malawi; Male; Proportional Hazards Models; Retrospective Studies; Rural Population; Stavudine; Survival Analysis; Tuberculosis, Pulmonary; Zidovudine	2016
The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS care, 2010, Volume: 22, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Retroviral Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Dietary Supplements; Drug Therapy, Combination; Female; HIV Infections; HIV Wasting Syndrome; Humans; Lamivudine; Linear Models; Malawi; Male; Middle Aged; Nevirapine; Retrospective Studies; Risk Factors; Soy Foods; Stavudine; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult; Zea mays	2010
Fat wasting--AZT vs. d4T. TreatmentUpdate, 2002, Volume: 14, Issue:8 Topics: HIV Infections; HIV Wasting Syndrome; Humans; Male; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine	2002
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine. Journal of clinical epidemiology, 2004, Volume: 57, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine	2004
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS (London, England), 1999, Sep-10, Volume: 13, Issue:13 Topics: Adipose Tissue; Adult; Aged; Body Composition; Cross-Sectional Studies; Energy Intake; Female; Glucose Tolerance Test; HIV Infections; HIV Wasting Syndrome; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Syndrome; Zidovudine	1999
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS (London, England), 2000, Jul-07, Volume: 14, Issue:10 Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cohort Studies; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors; Zidovudine	2000